Stay updated on Dara-Pembro Combo in Myeloma: Clinical Trial
Sign up to get notified when there's something new on the Dara-Pembro Combo in Myeloma: Clinical Trial page.

Latest updates to the Dara-Pembro Combo in Myeloma: Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe footer's ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check16 days agoChange DetectedA notice about NIH website changes and the transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record.SummaryDifference0.7%

- Check23 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check30 days agoChange DetectedThe footer now identifies the ClinicalTrials.gov site as revision v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check51 days agoChange DetectedAdded a new Revision: v3.7.0 to the record history and removed Revision: v3.6.6, indicating an update to the page's release notes. This change reflects an update to the version history rather than changes to the trial data or user-facing content.SummaryDifference0.1%

- Check72 days agoChange DetectedAdded revision v3.6.6 to the study record versions and removed revision v3.6.5 from the current listing to reflect the latest release history.SummaryDifference0.1%

Stay in the know with updates to Dara-Pembro Combo in Myeloma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dara-Pembro Combo in Myeloma: Clinical Trial page.